773 related articles for article (PubMed ID: 26193287)
61. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer.
Liu LZ; Fang J; Zhou Q; Hu X; Shi X; Jiang BH
Mol Pharmacol; 2005 Sep; 68(3):635-43. PubMed ID: 15947208
[TBL] [Abstract][Full Text] [Related]
62. Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells.
Tang XD; Zhou X; Zhou KY
Acta Pharmacol Sin; 2009 May; 30(5):605-16. PubMed ID: 19349962
[TBL] [Abstract][Full Text] [Related]
63. Activation of PI3K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells.
Zhang Z; Yu D; Yin D; Wang Z
Anim Reprod Sci; 2011 May; 125(1-4):42-8. PubMed ID: 21477953
[TBL] [Abstract][Full Text] [Related]
64. Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer.
Cheng CC; Guan SS; Yang HJ; Chang CC; Luo TY; Chang J; Ho AS
J Biomed Sci; 2016 Jan; 23():18. PubMed ID: 26822586
[TBL] [Abstract][Full Text] [Related]
65. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
66. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
67. The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway.
Tsai JL; Lee YM; Pan CY; Lee AY
Curr Cancer Drug Targets; 2016; 16(3):275-86. PubMed ID: 26882030
[TBL] [Abstract][Full Text] [Related]
68. DEPTOR Deficiency-Mediated mTORc1 Hyperactivation in Vascular Endothelial Cells Promotes Angiogenesis.
Ding Y; Shan L; Nai W; Lin X; Zhou L; Dong X; Wu H; Xiao M; Zhou X; Wang L; Li T; Fu Y; Lin Y; Jia C; Dai M; Bai X
Cell Physiol Biochem; 2018; 46(2):520-531. PubMed ID: 29614494
[TBL] [Abstract][Full Text] [Related]
69. Role of vincristine in the inhibition of angiogenesis in glioblastoma.
Park KJ; Yu MO; Park DH; Park JY; Chung YG; Kang SH
Neurol Res; 2016 Oct; 38(10):871-9. PubMed ID: 27472259
[TBL] [Abstract][Full Text] [Related]
70. Mechanism of hif-1α mediated hypoxia-induced permeability changes in bladder endothelial cells.
Liu C; Shui CL; Wang Q; Luo H; Gu CG
Braz J Med Biol Res; 2017 Dec; 51(2):e6768. PubMed ID: 29267502
[TBL] [Abstract][Full Text] [Related]
71. Mutant IkappaBalpha suppresses hypoxia-induced VEGF expression through downregulation of HIF-1alpha and COX-2 in human glioma cells.
Kimba Y; Abe T; Wu JL; Inoue R; Fukiki M; Kohno K; Kobayashi H
Oncol Res; 2005; 15(3):139-49. PubMed ID: 16050135
[TBL] [Abstract][Full Text] [Related]
72. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
[TBL] [Abstract][Full Text] [Related]
73. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
[TBL] [Abstract][Full Text] [Related]
74. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
75. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
Hamsa TP; Kuttan G
Drug Chem Toxicol; 2012 Jan; 35(1):57-70. PubMed ID: 22145808
[TBL] [Abstract][Full Text] [Related]
76. Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway.
Cui J; Gong R; Hu S; Cai L; Chen L
Life Sci; 2018 Jan; 192():293-303. PubMed ID: 29129773
[TBL] [Abstract][Full Text] [Related]
77. Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model.
Kowshik J; Giri H; Kishore TK; Kesavan R; Vankudavath RN; Reddy GB; Dixit M; Nagini S
Anticancer Agents Med Chem; 2014; 14(9):1249-60. PubMed ID: 25060902
[TBL] [Abstract][Full Text] [Related]
78. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals.
Zhao Y; You W; Zheng J; Chi Y; Tang W; Du R
Clin Transl Oncol; 2016 Nov; 18(11):1123-1130. PubMed ID: 26942921
[TBL] [Abstract][Full Text] [Related]
79. Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression.
Xue Y; Li NL; Yang JY; Chen Y; Yang LL; Liu WC
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2169-76. PubMed ID: 21357506
[TBL] [Abstract][Full Text] [Related]
80. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.
Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS
Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]